EN DE
Watch Cresud SA for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Cresud SA (CRES) fair value: what the stock is really worth

As of Nov 6, 2026: fair value (intrinsic value) of Cresud SA stock ARS 1,171, price ARS 1,519, that is 22.9% below the price, quality 27 out of 100. Rating: overvalued. Calculated from audited financials with 12 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Industrials AR · ISIN ARP331091024

CS Cresud SA logo Thin data Nov 6, 2026

Cresud SA

CRES · BA
Expensive, weak quality

Our calculation puts a fair price 23% below what the stock costs today.

Solidly profitable · 12.9% net margin (TTM)
Generates free cash flow
Costs just 6.1 times its yearly profit.
Expensive Growth (revenue 5y +100.7 %/yr in ARS)
Moderate debt
6.8% dividend yield · Watch coverage
Mixed vs. peers (8/14)
Moderate moat 54/100 · thin data
Fair value 1,171 ARS · Overvalued (−22.9%)
Quality 27/100
Thin data
⚠ Dilution
Watch Cresud SA for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

2,120 ARS 85.09 ARS Fair Value 1,171 ARS May 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 6, 2026.

How to read this chart

60‑month range 85.09 ARS – 2,120 ARS · fair‑value band 1,152 ARS – 1,278 ARS · the 1,519 ARS price screens above the 1,171 ARS fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 6, 2026.

Follow Cresud in your weekly email

Every Wednesday you see whether Cresud is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Cresud, Comercial, Inmobiliaria, Financiera y Agropecuaria, an agricultural company, engages in the production of agricultural commodities in Brazil and other Latin American countries. The company operates through Agricultural Business, and Business Urban Properties and Investments segments.

Show moreShow less

It is also involved in the management, development, and ownership of shopping malls, office buildings, and hotels; sale of grain derivatives, such as flour and oil; production and sale of crops, such as soybean, sugarcane, wheat, corn, oilseed, and sunflower, as well as sorghum and peanuts; and breeding, purchasing, and/or fattening of cattle for sale to slaughterhouses and supermarkets.

In addition, it leases its farms to third parties for agriculture, cattle breeding, and seed production; and offers agricultural services. The company was incorporated in 1936 and is headquartered in Buenos Aires, Argentina.

Stock analysis

Cresud SA (CRES) currently trades at 1,519 ARS, while our model-based Fair Value estimate is 1,171 ARS, 23% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Earnings-Based group reads highest at a median of 9,357 ARS per share, and 7 of the 12 models we run sit above the 1,519 ARS price.

Bear case: the Dividend Discount group reads lowest at 440.61 ARS, and 5 of the 12 models stay below the price. Data coverage for this calculation is low.

Scenario range: 1,152 ARS (bear) to 1,278 ARS (bull), the price of 1,519 ARS sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 27/100 (below-average quality), in the Industrials sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Cresud SA reported revenue of 1.4T ARS in FY2026 versus 95.9B ARS in FY2022, a compound +94.8%/yr. Reported net income was 177B ARS in FY2026, compounding +47.9%/yr from FY2022. FY2022 was a trough year, so the rate overstates the trend.

Key figures

Market cap 1.1T ARS (≈ $712M) Small · P/E ratio 6.1 · P/S ratio 0.72 · EPS (TTM) 248.66 ARS · Dividend yield 6.8% · Net margin 12.9% · Return on equity 12.2% · Return on assets (EBIT) 3.4% (5-year average).

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 54 out of 100 (low confidence).

What moves the price

The share trades about 28% below its 52-week high and at its 52-week low, currently below its 200-day average.

For context, the median of 10 Industrials peers we cover trades at 10% fair-value upside, at −23%, CRES screens richer than that median.

Fair Value models

Bear 1,152 ARS Fair Value 1,171 ARS Bull 1,278 ARS
Price 1,519 ARS · Downside -22.9%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2026 figures (about 4 months old). Earnings retained since then (51.96 ARS per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
Residual Income 1,355 ARS 1,377 ARS 1,504 ARS 76
Growth DCF n/a 54.18 ARS >216.72 ARS 74
Owner Earnings 711.93 ARS 1,668 ARS 3,068 ARS 71
All 12 models by family
DCF Models
Owner Earnings 711.93 ARS 1,668 ARS 3,068 ARS 71
5Y P/E Exit 1,350 ARS 4,254 ARS 8,244 ARS 65
10Y P/E Exit 508.50 ARS 2,224 ARS 5,071 ARS 56
Earnings-Based
Graham-Dodd 1,699 ARS 11,852 ARS 16,632 ARS 63
Lynch FV 4,804 ARS 6,863 ARS 8,922 ARS 61
Dividend Discount
Gordon GGM 315.86 ARS 433.31 ARS 494.95 ARS 69
DDM Multi-Stage 315.86 ARS 447.91 ARS 470.60 ARS 67
Multiples
P/E Multiple 3,936 ARS 5,248 ARS 6,560 ARS 63
P/B Multiple 6,726 ARS 8,968 ARS 11,210 ARS 55
Asset-Based
NCAV (Graham) 996.46 ARS 1,335 ARS 1,993 ARS 53
Growth DCF
Growth DCF n/a 54.18 ARS >216.72 ARS 74
Economic Profit
Residual Income 1,355 ARS 1,377 ARS 1,504 ARS 76

The fair value above starts from this blend and is adjusted for dilution from new shares.

Open the full fair value analysis →

Quality Score breakdown

Overall quality 27/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 31
How much profit the company makes from its sales and capital
Quality Growth 62
Are margins and returns getting better?
Cashflow 11
Do the profits arrive as real cash?
Financial strength 16
Debt, balance sheet and risk of trouble
Investment 29
Does it invest with discipline instead of growing at any price?
Low Volatility 68
How calm the share price moves, does not count
Price momentum 42
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 43
Distance to the 52-week high, does not count
New shares 9
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 62/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+13.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+93.5%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+100.7%
Start year 2021 (pandemic). Over 10 years: +44.2% a year
Revenue growth 10 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+44.2%
What shareholders gained per year (last 5 years), in ARS (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip. Measured in ARS: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+52.4%
Earnings growth per share plus dividend.
Earnings per share, growth per year+45.6%
Dividend (yield on the price)6.8%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.48.0% vs 56.6%, slowing
Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.30% → 17%
2026 sits 74% above its own trend. The rate follows the median trend of the last 5 years, not that single year.
Pace: the 5-year rate starts in 2021 (pandemic)

Growth Forecast

A lot of optimism in the price
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
more than +80 %
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.

CRES screens overvalued: fair value 23% below the price. Compare with 3M Company →

Compare Cresud SA with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Conglomerates · 305 stocks

Beats the industry median on 8/14 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 27 · Bottom 25%
Fair Value upside −22.9% · Below median
Profitability
Return on equity (12 months) 12.2% · Above median
Return on assets 5.2% · Above median
Net margin (12 months) 27.0% · Top 25%
Operating margin (12 months) 16.9% · Top 25%
Growth and dividend
Revenue growth (quarter YoY) 8.3% · Above median
Dividend yield (12 months) 6.8% · Top 25%
Balance sheet
Debt / equity 1.00× · Highest 25%

Valuation Multiplesvs Conglomerates median · lower = cheaper

P/E (12 months) 6.1× · Cheapest 25%
P/B 0.76× · Cheaper than median
P/S (12 months) 1.67× · Pricier than median
Price / free cash flow (fiscal year) 389.5× · Priciest 25%
EV/EBITDA 19.6× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)3 · sector 51
FUTURE (revenue growth)42 · sector 38
PAST (return on equity)49 · sector 29
HEALTH (low debt)50 · sector 89
DIVIDEND (yield)100 · sector 46

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Conglomerates stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
PT Astra International Tbk, ASII 5,000 IDR 9,860 IDR +97% vs CRES
SK Inc 034730 445,000 KRW 632,391 KRW +42% vs CRES
Honeywell International Inc HON $220.05 $245.42 +12% vs CRES
Kingdom Holding 4280 12.16 SAR 13.40 SAR +10% vs CRES
Jardine Matheson Holdings J36 $60.84 $66.74 +10% vs CRES
SGH Limited SGH A$42.46 A$34.87 −18% vs CRES
Keppel Ltd BN4 9.45 SGD 3.87 SGD −59% vs CRES
3M Company MMM $185.15 $73.02 −61% vs CRES
Swire Pacific Limited 0019 HK$112.20 HK$27.75 −75% vs CRES
Doosan Corporation 000150 638,000 KRW 95,752 KRW −85% vs CRES

Explore undervalued stocks

More undervalued Industrials stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cresud SA: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Cresud SA Fair Value". https://www.fairvalue-calculator.com/stock/CRES

Frequently asked questions

Is Cresud SA (CRES) overvalued or undervalued?
As of Nov 6, 2026, our model estimates a fair value of 1,171 ARS versus a price of 1,519 ARS, about 23% lower (overvalued).
What is the fair value of CRES?
Our model-based fair value for Cresud SA is 1,171 ARS (as of Nov 6, 2026), built from audited fundamentals. The current price: 1,519 ARS.
What is the quality score of CRES?
Cresud SA has a Quality Score of 27/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Cresud SA (CRES)?
Our model-based price target is the fair value of 1,171 ARS (as of Nov 6, 2026) from 12 valuation models. Cautious scenario 1,152 ARS, optimistic scenario 1,278 ARS. It is a calculation from audited fundamentals, not an analyst target.
What is the Cresud SA stock forecast for 2026?
Our models put fair value at 1,171 ARS, about 23% lower versus a price of 1,519 ARS (overvalued). Cautious scenario 1,152 ARS, optimistic scenario 1,278 ARS. The calculation is refreshed regularly with new filings.
What is the revenue of Cresud SA (CRES)?
Cresud SA reported trailing-twelve-month revenue of about 1.4T ARS (latest available figure, as of Nov 6, 2026).
Does Cresud SA pay a dividend?
Cresud SA currently shows a dividend yield of 6.84% relative to its recent price (as of Nov 6, 2026).
How much is the dividend of Cresud SA (CRES) and when is the ex-dividend date?
Cresud SA pays a dividend of 103.88 ARS per share a year, a dividend yield of 6.8%. The last ex-dividend date was Oct 27, 2026. The payout ratio is 41.8% of earnings. Free cash flow covers the dividend 0.08 times. Our assessment: Watch coverage. The dividend isn’t fully covered by free cash flow or earnings, part of it is funded from reserves or debt. Fine for now, but worth watching: if it stays uncovered, the dividend could be cut.
What growth is priced into Cresud SA (CRES)?
For today's price to be fair in a discounted-cash-flow model, Cresud SA would have to grow free cash flow by more than 80 % per year for five years (discount rate 20.7 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +100.7 % per year. As of Nov 6, 2026.
What discount rate (WACC) does the fair value of CRES use?
Our models discount Cresud SA at 20.7 %: a base by market capitalisation (small), country premium for Argentina. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Cresud SA that is more than 80 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (20.7 %) and the same formula as our fair value.
How much growth has Cresud SA (CRES) delivered so far?
Over the past 5 years revenue at Cresud SA grew +100.7 % a year. The price currently implies free-cash-flow growth of more than 80 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Cresud SA (CRES) growing?
The median revenue growth in the sector is +7.8 % a year. That is the yardstick for the growth priced into Cresud SA (more than 80 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Cresud SA (CRES)?
The free-cash-flow yield on the price is 0.55 %: that much free cash flow Cresud SA produces per unit of market value. When it exceeds the discount rate of our models (20.7 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Cresud SA (CRES)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Cresud SA it is 1,171 ARS per share (as of Nov 6, 2026), against a price of 1,519 ARS. It is the blended result of 12 valuation models in 7 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit).
Is Cresud SA stock overvalued or undervalued in 2026?
As of Nov 6, 2026, CRES trades above its calculated fair value: price 1,519 ARS, fair value 1,171 ARS, a gap of about −23% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of CRES?
No. The price is what the market pays today (1,519 ARS); the fair value is what the company's own numbers justify (1,171 ARS). For Cresud SA the two are 348.17 ARS per share apart. That gap is exactly why we show both numbers side by side.
How much is Cresud SA worth?
The market values Cresud SA at about 1.1T ARS (market capitalisation, as of Nov 6, 2026). Per share that is 1,519 ARS; our models calculate a fair value of 1,171 ARS per share.
What do the bullish and bearish scenarios say about CRES?
Our models span a range for Cresud SA: cautious scenario 1,152 ARS, base 1,171 ARS, optimistic 1,278 ARS per share (as of Nov 6, 2026, price 1,519 ARS). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of CRES?
Cresud SA trades at a price-to-earnings ratio of 6.1 (as of Nov 6, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 1,171 ARS is built from several models across several years. Other multiples: P/B 0.8, P/S 1.7, EV/EBITDA 19.6.
How solid is the balance sheet of Cresud SA (CRES)?
Balance-sheet figures for Cresud SA (as of Nov 6, 2026): return on equity 12.2%, debt of 1.00 per unit of equity. They feed the Quality Score of 27/100, which measures business quality independently of the share price.
How far is CRES from its 52-week high?
Cresud SA trades at 1,519 ARS, about 28% below its 52-week high of 2,120 ARS and at the low of 1,515 ARS (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of 1,171 ARS is for.
Which stocks are comparable to Cresud SA?
From the same area (Industrials) we also value 3M Company, Honeywell International Inc, Swire Pacific Limited, SGH Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Cresud SA stock attractive at the current price?
The data as of Nov 6, 2026: price 1,519 ARS, calculated fair value 1,171 ARS (−23%), Quality Score 27/100, from 12 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of CRES calculated?
We run Cresud SA through 12 models from 7 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit. Every model gets the same audited fundamentals; the fair value of 1,171 ARS builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0% above its aggregate fair value. Cresud SA itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Cresud SA (CRES)?
The closing price on Nov 6, 2026 was 1,519 ARS. Our model-based fair value is 1,171 ARS, about 23% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Cresud SA right now?
The price sits above even our optimistic bull case (1,278 ARS). The favourable scenario is already priced in. Weak quality (27/100) and above fair value at the same time, the margin of safety is missing on both counts. The models converge in a tight band (1,152 ARS to 1,278 ARS), unusually little disagreement for a valuation. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Cresud SA

How large is the market capitalisation of Cresud SA (CRES)?
The market capitalisation of Cresud SA is 1.1T ARS (≈ $712M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Cresud SA (CRES)?
The price-to-sales ratio of Cresud SA is 0.72 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Cresud SA (CRES)?
Earnings per share at Cresud SA are 248.66 ARS (price ÷ EPS = P/E 6.1). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Cresud SA (CRES)?
The dividend yield of Cresud SA is 6.8% (payout 41.8%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Cresud SA (CRES)?
The net margin of Cresud SA is 12.9% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Cresud SA (CRES)?
The return on equity (ROE) of Cresud SA is 12.2% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Cresud SA (CRES)?
On an EBIT basis the return on assets of Cresud SA is 3.4% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Cresud SA (CRES)?
The operating margin of Cresud SA is 16.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Cresud SA (CRES)?
Revenue at Cresud SA is growing +8.3% versus a year earlier (3y avg +93.5%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Cresud SA (CRES)?
Earnings per share at Cresud SA are growing −50.3% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Cresud SA (CRES) carry?
The net debt of Cresud SA is 1.7T ARS (fiscal year 2026). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Cresud SA in the live analysis

One click puts Cresud SA on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.